70 filings
8-K
DNLI
Denali Therapeutics Inc
27 Feb 24
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
8:07am
8-K
DNLI
Denali Therapeutics Inc
27 Feb 24
Denali Therapeutics Announces $500 million Private Placement Equity Financing
8:03am
8-K
DNLI
Denali Therapeutics Inc
16 Feb 24
Regulation FD Disclosure
8:02am
8-K
DNLI
Denali Therapeutics Inc
8 Jan 24
Regulation FD Disclosure
8:06am
8-K
DNLI
Denali Therapeutics Inc
7 Nov 23
Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
0k8 c1nphoe
21 Aug 23
Entry into a Material Definitive Agreement
4:06pm
8-K
1r8 1322zzhxdafdict
8 Aug 23
Denali Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
530zjf8ot0pruv
20 Jun 23
Other Events
7:03am
8-K
pp4xxru59
5 Jun 23
Other Events
8:12am
8-K
58b6jer94j7gud
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
uxqmcf9ha5k
8 May 23
Denali Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
4:03pm
8-K
ttlai c1s4
27 Feb 23
Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
4:04pm
8-K
f3jrpp8
9 Jan 23
Denali Therapeutics Announces Key Anticipated 2023 Milestones for Its Therapeutic Portfolio for Neurodegeneration and Lysosomal Storage Diseases
8:08am
8-K
1mfciyi 5az
3 Nov 22
Denali Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
4:05pm
8-K
h9qhm 3o0ta1qujz3s
20 Oct 22
Denali Therapeutics Announces Pricing of $275 Million Public Offering of Common Stock
4:58pm
8-K
wcm5g98ikc2728r hno
18 Oct 22
Denali Therapeutics Announces Proposed Offering of Common Stock
5:09pm
8-K
hrjwsj 1e
8 Aug 22
Denali Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
4:03pm
8-K
lycj5k gu
5 Jul 22
Regulation FD Disclosure
8:01am
8-K
rxqrsxag64rxik
3 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
ekn5d0mbka7zsho1nbfb
5 May 22
Denali Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
4:03pm